Takeo Yoshihara
Suita, 5650871, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Risk of lymph-node metastasis in early onset T1 colorectal cancer: a systematic review and meta-analysis.
Journal: Journal of gastroenterology
Published: March 12, 2026
Selective Drug-Free Active Surveillance in Ulcerative Colitis: Biomarker-Guided, Patient-Centered Approach.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: December 26, 2025
Successful Hemostasis by Double-balloon Enteroscopy with Mini-laparotomy for Small-bowel Hemorrhage in a Patient with LVAD.
Journal: Internal medicine (Tokyo, Japan)
Published: October 01, 2025
Serum leucine-rich α-2-glycoprotein and monocyte chemoattractant protein-1 as novel biomarkers for predicting vedolizumab response in patients with ulcerative colitis.
Journal: Crohn's & colitis 360
Published: September 19, 2025
Suppressing FUT8 with a Novel Small Molecule Inhibitor Ameliorates Inflammation in Murine T Cell-mediated Colitis Models.
Journal: Cellular and molecular gastroenterology and hepatology
Published: July 24, 2025
Fecal microbiota transplantation for Crohn's disease-like intestinal lesions arising after allogeneic stem cell transplantation.
Journal: International journal of hematology
Published: June 06, 2025
Outcomes of additional chemotherapy for esophageal squamous cell carcinoma following non-curative endoscopic submucosal dissection.
Journal: International journal of clinical oncology
Published: May 05, 2025
Safety and Effectiveness of Oral Budesonide after Endoscopic Balloon Dilation in Patients with Crohn's Disease: A Multicenter Prospective Intervention Study.
Journal: Inflammatory intestinal diseases
Published: April 21, 2025
Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study.
Journal: Crohn's & colitis 360
Published: February 25, 2025
Generation and validation of antibody 42B1 recognizing galactose-deficient IgG for diagnosis of chronic inflammatory diseases.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: September 27, 2024
Last Updated: 09/26/2026